Medicine put to the test

The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients. We provide information about the advantages and disadvantages of examination and treatment methods in the form of scientific reports and easily understandable health information.

Latest news

Press Releases

Press Releases

Spinal muscular atrophy (SMA): newborn screening promises a benefit

2020-03-27 The earliest possible diagnosis and treatment of infantile SMA through newborn screening leads to better motor development and less need for permanent ventilation as well as fewer deaths.

read more Link to \Spinal muscular atrophy (SMA): newborn screening promises a benefit\""

Dupilumab for chronic rhinosinusitis with nasal polyposis: proof of added benefit

2020-03-02 The extent is non-quantifiable, but at least considerable. Positive effects in several symptom outcomes are not accompanied by negative effects.

read more Link to \Dupilumab for chronic rhinosinusitis with nasal polyposis: proof of added benefit\""

Biomarker tests for decision-making on chemotherapy for breast cancer: No evidence of transferability

2020-02-27 27.02.2020 The tests assign different women to the group “low risk of recurrence”. It thus remains unclear who could omit chemotherapy.

read more Link to \Biomarker tests for decision-making on chemotherapy for breast cancer: No evidence of transferability\""

Breast cancer surgery: better results with higher case numbers

2020-02-10 Increased chances of survival and fewer follow-up operations – positive correlation between volume and quality in the surgical treatment of breast cancer.

read more Link to \Breast cancer surgery: better results with higher case numbers\""

IQWiG supports the "Jena Declaration”

2020-02-10 The Institute no longer translates the term “race” as “Rasse” in its assessments; instead, the term “Abstammung” (origin) is used.

read more Link to \IQWiG supports the "Jena Declaration”\""

Larotrectinib in tumours with NTRK gene fusion: Data are not yet sufficient for derivation of an added benefit

2020-01-15 The small studies on the histology-independent use of the inhibitor have no controls. The amount of other data is also still too small to assess an added benefit.

read more Link to \Larotrectinib in tumours with NTRK gene fusion: Data are not yet sufficient for derivation of an added benefit\""

Asfotase alfa in hypophosphatasia in childhood and adolescence: survival benefit for infants

2020-01-15 More infants survive congenital metabolic disorder under enzyme replacement therapy. Due to lack of data it is unclear whether older children, adolescents and adults also benefit.

read more Link to \Asfotase alfa in hypophosphatasia in childhood and adolescence: survival benefit for infants\""

An appeal for independent research and decision-making: How to produce trustworthy evidence for healthcare decisions without commercial interference

2019-12-05 We all want to base our healthcare decisions on trustworthy evidence. But often enough, financial ties between the pharmaceutical and medical devices industry and healthcare players lead to bias in th…

read more Link to \An appeal for independent research and decision-making: How to produce trustworthy evidence for healthcare decisions without commercial interference\""

Current commenting procedures (Hearings)

Current commenting procedures (Hearings)

No Title Type Deadline
P17-01Information for health insurance fund members on prenatal testing zum Vorbericht 29.05.2020

Calls for tenders advertised

Calls for tenders advertised

In general, calls for tenders are published in German. Interested parties can check current calls for tenders on the German website.


Easily understandable information for patients and the general community

How can I find good-quality information about the coronavirus?

The coronavirus is on everyone’s mind right now. Many people are finding out about it on the internet or from sharing on social networks. There is a lot of good information on the internet – but unfortunately plenty of misinformation as well. Read about finding good-quality information on the coronavirus.   read more (Link to \How can I find good-quality information about the coronavirus?\"" ‚Äì opens in a new window)


Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close